HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Rolland Selected Research

Sirtuins

6/2022A new software tool for planning interventional procedures in liver cancer.
1/2022Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.
11/2021Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas.
7/2021ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma.
10/2020Downstaging with Radioembolization or Chemotherapy for Initially Unresectable Intrahepatic Cholangiocarcinoma.
8/2020Lymphocytes and Neutrophil-to-Lymphocyte Ratio Variations After Selective Internal Radiation Treatment for HCC: A Retrospective Cohort Study.
6/2020Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design.
1/2020Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
5/201990Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry.
3/2018Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocol.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Rolland Research Topics

Disease

21Hepatocellular Carcinoma (Hepatoma)
06/2022 - 11/2003
15Neoplasms (Cancer)
10/2020 - 01/2010
7Liver Neoplasms (Liver Cancer)
06/2022 - 11/2003
6Cholangiocarcinoma
11/2021 - 11/2015
5Thrombosis (Thrombus)
05/2019 - 01/2010
3Neoplasm Metastasis (Metastasis)
03/2016 - 03/2010
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019 - 11/2015
2Hypertrophy
01/2018 - 08/2013
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 01/2017
1Ascites
01/2021
1Jaundice (Icterus)
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Liver Failure
01/2021
1Adenocarcinoma
01/2017
1Fibrosis (Cirrhosis)
03/2016
1Pain (Aches)
06/2012
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2010

Drug/Important Bio-Agent (IBA)

13SirtuinsIBA
06/2022 - 11/2015
6AlbuminsIBA
01/2021 - 12/2011
5Yttrium-90IBA
11/2021 - 08/2016
3Ethiodized Oil (Ethiodol)FDA Link
07/2019 - 11/2003
3Sorafenib (BAY 43-9006)FDA Link
04/2016 - 01/2012
1Alanine Transaminase (SGPT)IBA
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1mahuang-tangIBA
01/2018
1macro aggregates of albuminIBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2010
1Prednisone (Sone)FDA LinkGeneric
12/2010
1Rituximab (Mabthera)FDA Link
12/2010
1Vincristine (Oncovin)FDA LinkGeneric
12/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2010
1Radioisotopes (Radionuclides)IBA
01/2010
1Iodine-131IBA
09/2008
1Biological ProductsIBA
11/2003

Therapy/Procedure

21Microspheres (Microsphere)
11/2021 - 01/2010
17Radiotherapy
06/2022 - 09/2008
7Therapeutics
06/2022 - 01/2010
7Drug Therapy (Chemotherapy)
06/2022 - 11/2015
2Intra-Arterial Injections
01/2010 - 11/2003
1Contraindications
01/2021
1Immunotherapy
08/2020
1Catheters
03/2018
1Cementoplasty
06/2012